Breaking News Instant updates and real-time market news.

INFY

Infosys

$11.19

0.02 (0.18%)

06:43
10/11/19
10/11
06:43
10/11/19
06:43

Infosys reports Q2 EPS 13c, consensus 13c

Reports Q2 revenue $3.21B, consensus $3.19B. "Q2 witnessed another quarter of all-round growth in industry segments and geographies which is a testimony to our strong credentials and client relevance", said Pravin Rao, COO. "Large deal wins were $2.8B. We are especially pleased by the reduction in attrition driven by our focus on enhanced employee value proposition."

  • 11

    Oct

INFY Infosys
$11.19

0.02 (0.18%)

07/12/19
SBSH
07/12/19
UPGRADE
SBSH
Buy
Citi upgrades Infosys to Buy following 'multiple positives' in Q1 report
As previously reported, Citi analyst Surrendra Goyal upgraded Infosys to Buy from Neutral following the "multiple positives" in the company's Q1 report, which include deal wins, a revenue guidance hike and an increase in plans for capital returns. While the analyst's EPS forecasts are largely unchanged after the report, Goyal raised the multiple applied and increased the price target for the shares to Rs820 from Rs785.
07/15/19
NOMU
07/15/19
UPGRADE
NOMU
Neutral
Infosys upgraded to Neutral from Reduce at Nomura Instinet
09/16/19
UBSW
09/16/19
DOWNGRADE
UBSW
Neutral
Infosys downgraded to Neutral from Buy at UBS
09/16/19
UBSW
09/16/19
DOWNGRADE
UBSW
Neutral
Infosys downgraded to Neutral from Buy at UBS
UBS analyst Diviya Nagarajan downgraded Infosys to Neutral, but raised his price target to INR900 from INR850. The analyst notes that the stock price has rallied by 28% year to date while its multiple is now over two standard deviation intervals above its 5-year average. Nagarajan further warns that the looming demand concerns put sector valuations at risk, and he is "unwilling to argue" for a higher earnings multiple for Infosys at these levels.

TODAY'S FREE FLY STORIES

TEUM

Pareteum

$0.74

-0.0948 (-11.42%)

07:57
10/22/19
10/22
07:57
10/22/19
07:57
Downgrade
Pareteum rating change  »

Pareteum downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HAL

Halliburton

$19.60

1.16 (6.29%)

07:56
10/22/19
10/22
07:56
10/22/19
07:56
Recommendations
Halliburton analyst commentary  »

Halliburton guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$19.60

1.16 (6.29%)

07:55
10/22/19
10/22
07:55
10/22/19
07:55
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
U.S. chain store sales rebounded 3.1% in the October 19 week »

U.S. chain store sales…

07:55
10/22/19
10/22
07:55
10/22/19
07:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

FBP

First BanCorp

$10.24

-0.015 (-0.15%)

07:54
10/22/19
10/22
07:54
10/22/19
07:54
Earnings
First BanCorp reports Q3 EPS 21c, consensus 19c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:53
10/22/19
10/22
07:53
10/22/19
07:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

LNXSF

Lanxess

$0.00

(0.00%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Downgrade
Lanxess rating change  »

Lanxess downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNW

Genworth

$4.31

0.01 (0.23%)

07:51
10/22/19
10/22
07:51
10/22/19
07:51
Hot Stocks
Genworth receives feedback from Canadian regulators regarding transaction »

Genworth Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

TREE

LendingTree

$317.86

3.4 (1.08%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

  • 19

    Nov

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

, EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Hot Stocks
EQT Midstream Partners-owned MVP says project work will be 90% complete by 2020 »

Mountain Valley announced…

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 05

    Nov

SNN

Smith & Nephew

$43.65

-4.165 (-8.71%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
Smith & Nephew analyst commentary  »

Smith & Nephew CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$146.64

0.5 (0.34%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Initiation
Vulcan Materials initiated  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BBIO

BridgeBio

$18.54

0.29 (1.59%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Hot Stocks
BridgeBio announces presentation of data from subsidiaries studies »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$93.74

0.885 (0.95%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Initiation
TE Connectivity initiated  »

TE Connectivity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

MBRX

Moleculin Biotech

$1.07

-0.005 (-0.47%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Hot Stocks
Moleculin Biotech raises Annamycin production »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Earnings
Breaking Earnings news story on NextEra Energy Partners »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 04

    Dec

AX

Axos Financial

$29.97

0.54 (1.83%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Hot Stocks
Newbridge Securities enters five-year clearing agreement with Axos Clearing »

Newbridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 06

    Nov

  • 04

    Dec

  • 05

    Dec

CVA

Covanta

$17.06

0.31 (1.85%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Downgrade
Covanta rating change  »

Covanta double downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

APH

Amphenol

$100.40

1.35 (1.36%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Initiation
Amphenol initiated  »

Amphenol initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

MAIN

Main Street

$42.50

0.23 (0.54%)

07:41
10/22/19
10/22
07:41
10/22/19
07:41
Downgrade
Main Street rating change  »

Main Street downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

, OPK

Opko Health

$2.12

0.03 (1.44%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Recommendations
Ascendis Pharma, Opko Health, Pfizer analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

OPK

Opko Health

$2.12

0.03 (1.44%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Hot Stocks
Callon Petroleum files presentation highlighting benefits of Carrizo deal »

Callon Petroleum Company…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

BAND

Bandwidth

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Bandwidth rating change  »

Bandwidth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCC

Ares Capital

$18.70

0.14 (0.75%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Downgrade
Ares Capital rating change  »

Ares Capital downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.